Logo image of CJJD

CHINA JO-JO DRUGSTORES HOLDI (CJJD) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:CJJD - KYG2124G1203 - Common Stock

1.52 USD
-0.09 (-5.59%)
Last: 3/3/2025, 8:22:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
CJJD revenue by date.CJJD revenue by date.
164.393M
23.48%
148.812M
-9.48%
154.541M
3.85%
EBITDA
YoY % growth
CJJD ebitda by date.CJJD ebitda by date.
-1.289M
81.20%
-20.207M
-1,467.65%
-2.744M
86.42%
EBIT
YoY % growth
CJJD ebit by date.CJJD ebit by date.
-2.545M
70.43%
-20.925M
-722.20%
-3.535M
83.11%
Operating Margin
CJJD operating margin by date.CJJD operating margin by date.
-1.55%-14.06%-2.29%
EPS
YoY % growth
CJJD eps by date.CJJD eps by date.
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
71.16M
-9.44%
%
Q4 2024
Q2Q % growth
75.967M
-0.16%
%
Q2 2024
Q2Q % growth
78.574M
8.05%
%
Q4 2023
Q2Q % growth
76.09M
-11.43%
%
Q2 2023
Q2Q % growth
72.722M
-7.34%
%
Q4 2022
Q2Q % growth
85.908M
140.65%
%
Q2 2022
Q2Q % growth
78.484M
154.46%
%
Q4 2021
Q2Q % growth
35.699M
17.70%
%
Q3 2021
Q2Q % growth
35.539M
6.52%
%
Q2 2021
Q2Q % growth
30.843M
8.78%
%
Q1 2021
Q2Q % growth
31.054M
22.84%
%
CJJD Yearly Revenue VS EstimatesCJJD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A